phosphotyrosine has been researched along with MEA 2a in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, N; Iwashita, T; Matsuyama, M; Takahashi, M | 1 |
| Attié, T; Billaud, M; Chappuis-Flament, S; De Vita, G; Fusco, A; Lenoir, GM; Pasini, A; Santoro, M; Ségouffin-Cariou, C | 1 |
| Asai, N; Iwashita, T; Iwata, Y; Kawai, K; Murakami, H; Shimono, Y; Takahashi, M | 1 |
| Akhand, AA; Hamaguchi, M; Iwashita, T; Kato, M; Kawamoto, Y; Nakashima, I; Senga, T; Sobue, G; Takahashi, M; Takeda, K; Yamamoto, M | 1 |
4 other study(ies) available for phosphotyrosine and MEA 2a
| Article | Year |
|---|---|
Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Biotin; Blotting, Western; Cadherins; Cell Transformation, Neoplastic; Cytomegalovirus; Drosophila Proteins; Gene Expression Regulation, Neoplastic; Humans; Mice; Multiple Endocrine Neoplasia Type 2a; Mutagenesis, Site-Directed; Phosphotyrosine; Point Mutation; Promoter Regions, Genetic; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Simian virus 40; Transfection; Tyrosine | 1995 |
Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines.
Topics: 3T3 Cells; Amino Acid Substitution; Animals; Cell Transformation, Neoplastic; Cysteine; Dimerization; Disulfides; Drosophila Proteins; Glycosylation; Hirschsprung Disease; Humans; Membrane Proteins; Mice; Models, Biological; Multiple Endocrine Neoplasia Type 2a; PC12 Cells; Phosphotyrosine; Precipitin Tests; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Rats; Receptor Protein-Tyrosine Kinases; Transcriptional Activation | 1998 |
Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation.
Topics: Adaptor Proteins, Signal Transducing; DNA-Binding Proteins; Drosophila Proteins; Enzyme Activation; Glial Cell Line-Derived Neurotrophic Factor; Glial Cell Line-Derived Neurotrophic Factor Receptors; GTPase-Activating Proteins; Humans; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Mutation; Nerve Growth Factors; Nerve Tissue Proteins; Neuroblastoma; Oncogene Proteins; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; ras GTPase-Activating Proteins; Receptor Protein-Tyrosine Kinases; RNA-Binding Proteins; Signal Transduction; Transfection; Tumor Cells, Cultured | 1999 |
Repair by Src kinase of function-impaired RET with multiple endocrine neoplasia type 2A mutation with substitutions of tyrosines in the COOH-terminal kinase domain for phenylalanine.
Topics: 3T3 Cells; Amino Acid Substitution; Animals; Catalysis; Cell Transformation, Neoplastic; Drosophila Proteins; Humans; Mice; Multiple Endocrine Neoplasia Type 2a; Mutagenesis; Phenylalanine; Phosphorylation; Phosphotyrosine; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; src-Family Kinases; Transfection; Tyrosine | 2002 |